Thioguanine‐nucleotides do not predict efficacy of tioguanine in Crohn's disease
Klaus Herrlinger(Robert Bosch Hospital), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Klaus Fellermann(Apple (Israel)), Juergen Schöelmerich(University of Regensburg), Aki Sebastian Ruhl(Heidelberg University), Christine Fischer, Peter Deibert(University of Freiburg), Roland Greinwald(Dr Falk Pharma (Germany)), Wolfgang E. Fleig(University Hospital Leipzig), Wolfgang Kreisel(University of Freiburg), Max Reinshagen(Evangelisches Krankenhaus Göttingen-Weende), Eduard F. Stange(John Radcliffe Hospital)
Cited by 42
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data
|Journal of Clinical Oncology|2006|1.2k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
Early Experience Alters Brain Function and Structure
|PEDIATRICS|2004|884